StockGuru News: The Immune Response Corporation (OTCBB: IMNR) Receives Approval for Expansion of Phase II Trial in France for Investigative HIV Immunotherapy IR103
The Immune Response Corporation (OTCBB: IMNR) The Immune Response Corporation Receives Approval for Expansion of Phase II Trial in France…